Christian Schem

机构：Mammazentrum Hamburg, Krankenhaus Jerusalem · ORCID：0000-0001-8606-3077

发表论文 445 篇 · 总被引 8603 次 · h-index 38

代表论文

• Molecular adaptation to neoadjuvant immunotherapy in triple-negative breast cancer (2024 · Cell Reports Medicine · 被引 21)
• 189O Ribociclib + endocrine treatment vs SoC chemotherapy in intermediate risk HR+/HER2- early breast cancer: Results from the neoadjuvant cohort of the phase-III WSG ADAPTcycle – trial (2025 · ESMO Open · 被引 12)
• Surrogate End Points for Overall Survival in Neoadjuvant Randomized Clinical Trials for Early Breast Cancer (2025 · Journal of Clinical Oncology · 被引 9)
• On-treatment biopsies to predict response to neoadjuvant chemotherapy for breast cancer (2024 · Breast Cancer Research · 被引 8)
• Distant disease-free survival as a surrogate endpoint for overall survival in randomised trials of neoadjuvant therapy for early breast cancer: a pooled analysis of GBG and AGO-B Study Group trials (2025 · The Lancet Oncology · 被引 7)
• Prediction of survival after de-escalated neoadjuvant therapy in HER2-positive early breast cancer: a pooled analysis of three WSG trials (2025 · Annals of Oncology · 被引 6)